Case Study: ResMed speeds products to market with Objective Corporation

ResMed meets stringent biomedial regulations and expedites time to market

ResMed, Australia’s largest manufacturer and exporter of medical devices, needed a better way to manage large volumes of regulated content across a fast-growing global operation. Working with Objective Corporation, the company rolled out Objective’s content, collaboration and process management solution to support more than 1,400 users in 18 countries and to help meet strict biomedical and quality regulations while speeding product development.

Objective Corporation implemented a mission-critical system to manage electronic and hard copy records, automate approvals, and improve version control and document access across ResMed’s manufacturing and regulatory teams. The result was faster review cycles, less paperwork and labour, stronger compliance with FDA, TGA and ISO 9000 requirements, and quicker access to documents for auditors—cutting approval turnaround from up to two weeks to minutes in some cases.

ResMed

Lionel King

Vice President of Quality Assurance & Regulatory Affairs